We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Second Malignant Neoplasms After Childhood ALL Therapy (PdL-SMN1)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01476462
First Posted: November 22, 2011
Last Update Posted: May 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Nordic Society for Pediatric Hematology and Oncology
European Organisation for Research and Treatment of Cancer - EORTC
Dana-Farber Cancer Institute
ALL-BFM Study Group
Dutch Childhood Oncology Group
St. Jude Children's Research Hospital
United Kingdom Children's Cancer Study Group
Information provided by (Responsible Party):
Kjeld Schmiegelow, Rigshospitalet, Denmark
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)